NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ: 089140)

NEXTURNBIOSCIENCE Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2010
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2010
Market Capitalization	40,707	51,872	65,856	200,064	124,142	27,910
Market Cap Growth	-46.59%	-21.23%	-67.08%	61.16%	344.80%	23.07%
Enterprise Value	89,584	86,701	126,455	191,439	117,721	21,975
Last Close Price	3610.00	5520.00	8475.00	31200.00	19833.33	4636.10
PE Ratio	-	6.23	-	-	-	-
PS Ratio	0.98	1.26	2.81	11.79	12.82	1.11
PB Ratio	0.29	0.38	0.61	2.16	1.28	1.29
P/TBV Ratio	0.26	0.38	0.63	2.16	1.28	1.30
P/FCF Ratio	-	-	-	62.58	-	-
P/OCF Ratio	-	-	-	54.60	526.16	-
EV/Sales Ratio	2.47	2.10	5.39	11.28	12.15	0.88
EV/EBITDA Ratio	99.88	118.47	-	-	-	6.50
EV/EBIT Ratio	-	-	-	-	-	7.32
EV/FCF Ratio	-16.96	-	-	59.88	-	-
Debt / Equity Ratio	0.60	0.56	0.70	0.31	0.00	-
Debt / EBITDA Ratio	100.95	104.90	-	-	-	-
Debt / FCF Ratio	-	-	-	8.88	-	-
Asset Turnover	0.15	0.19	0.14	0.14	-	-
Inventory Turnover	3.47	4.84	2.93	1.98	-	-
Quick Ratio	1.42	0.41	1.84	1.05	27.58	-
Current Ratio	1.93	0.50	2.23	1.18	32.29	-
Return on Equity (ROE)	-16.36%	7.53%	-4.85%	-4.68%	-	12.05%
Return on Assets (ROA)	-0.28%	-0.36%	-1.67%	-1.25%	-	-
Return on Capital (ROIC)	-0.31%	-0.40%	-1.86%	-1.37%	-	9.04%
Earnings Yield	-71.62%	18.66%	-7.12%	-2.22%	-1.96%	8.96%
FCF Yield	-12.97%	-5.87%	-2.14%	1.60%	-0.79%	-
Buyback Yield / Dilution	-25.94%	-48.59%	-5.86%	-	-	-
Total Shareholder Return	-25.94%	-48.59%	-5.86%	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.